相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Locations of disulfide bonds and free cysteines in the heavy and light chains of recombinant human factor VIII (antihemophilic factor A)
Brad A. Mcmullen et al.
PROTEIN SCIENCE (2010)
Enhanced efficacy of recombinant FVIII in noncovalent complex with PEGylated liposome in hemophilia A mice
Junliang Pan et al.
BLOOD (2009)
Pharmacokinetics and dose requirements of factor VIII over the age range 3-74 years
Sven Bjorkman et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2009)
PEG-modified biopharmaceuticals
Pascal Bailon et al.
EXPERT OPINION ON DRUG DELIVERY (2009)
The impact of PEGylation on biological therapies
Francesco M. Veronese et al.
BIODRUGS (2008)
The pharmacology of PEGylation: Balancing PD with PK to generate novel therapeutics
C. Simone Fishburn
JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index
Jagath R. Junutula et al.
NATURE BIOTECHNOLOGY (2008)
Crystal structure of human factor VIII: Implications for the formation of the factor IXa-factor VIIIa complex
Jacky Chi Ki Ngo et al.
STRUCTURE (2008)
Extending half-life in coagulation factors: where do we stand?
David Lillicrap
THROMBOSIS RESEARCH (2008)
Clearance mechanisms of von Willebrand factor and factor VIII
P. J. Lenting et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Design of a long acting peptide functioning as both a glucagon-like peptide-1 receptor agonist and a glucagon receptor antagonist
CQ Pan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Epitope mapping factor VIII A2 domain by affinity-directed mass spectrometry: residues 497-510 and 584-593 comprise a discontinuous epitope for the monoclonal antibody R8B12
C Ansong et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Characterization of factor VIII inhibitors
M Shima
INTERNATIONAL JOURNAL OF HEMATOLOGY (2006)
Role of the C2 domain of factor VIIIa in the assembly of factor-X activating complex on the platelet membrane
SS Ahmad et al.
BIOCHEMISTRY (2005)
LDL receptor cooperates with LDL receptor-related protein in regulating plasma levels of coagulation factor VIII in vivo
N Bovenschen et al.
BLOOD (2005)
The B domain of coagulation factor VIII interacts with the asialoglycoprotein receptor
N Bovenschen et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Inhibitors in hemophilia A: Mechanisms of inhibition, management and perspectives
NM Ananyeva et al.
BLOOD COAGULATION & FIBRINOLYSIS (2004)
Low density lipoprotein receptor-related protein and factor IXa share structural requirements for binding to the A3 domain of coagulation factor VIII
N Bovenschen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Versatile expression system for rapid and stable production of recombinant proteins
MS Cho et al.
BIOTECHNOLOGY PROGRESS (2003)
Chemistry for peptide and protein PEGylation
MJ Roberts et al.
ADVANCED DRUG DELIVERY REVIEWS (2002)
Recombinant von Willebrand factor -: Insight into structure and function through infusion studies in animals with severe von Willebrand disease
HP Schwarz et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2002)
3-Dimensional structure of membrane-bound coagulation factor VIII: modeling of the factor VIII heterodimer within a 3-dimensional density map derived by electron crystallography
S Stoilova-McPhie et al.
BLOOD (2002)
Cell surface heparan sulfate proteoglycans participate in factor VIII catabolism mediated by low density lipoprotein receptor-related protein
AG Sarafanov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
B-domain deleted recombinant coagulation factor VIII modified with monomethoxy polyethylene glycol
J Röstin et al.
BIOCONJUGATE CHEMISTRY (2000)
分享论文
